CN1516598A - 抗菌肽 - Google Patents

抗菌肽 Download PDF

Info

Publication number
CN1516598A
CN1516598A CNA028121910A CN02812191A CN1516598A CN 1516598 A CN1516598 A CN 1516598A CN A028121910 A CNA028121910 A CN A028121910A CN 02812191 A CN02812191 A CN 02812191A CN 1516598 A CN1516598 A CN 1516598A
Authority
CN
China
Prior art keywords
seq
peptide
amino acid
sequence
purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028121910A
Other languages
English (en)
Chinese (zh)
Inventor
���˹M���±�
查尔斯M·德贝
刘利平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children
Original Assignee
Hospital for Sick Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children filed Critical Hospital for Sick Children
Publication of CN1516598A publication Critical patent/CN1516598A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CNA028121910A 2001-06-22 2002-06-21 抗菌肽 Pending CN1516598A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29972601P 2001-06-22 2001-06-22
US60/299,726 2001-06-22

Publications (1)

Publication Number Publication Date
CN1516598A true CN1516598A (zh) 2004-07-28

Family

ID=23156022

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028121910A Pending CN1516598A (zh) 2001-06-22 2002-06-21 抗菌肽

Country Status (9)

Country Link
US (2) US20040235745A1 (enExample)
EP (1) EP1401478A2 (enExample)
JP (1) JP2004534084A (enExample)
CN (1) CN1516598A (enExample)
AU (1) AU2002317071B2 (enExample)
CA (1) CA2451310C (enExample)
IL (1) IL159274A0 (enExample)
WO (1) WO2003000277A2 (enExample)
ZA (1) ZA200309580B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102481369A (zh) * 2009-06-16 2012-05-30 东海大学 抗革兰氏阴性菌剂
CN103221383A (zh) * 2010-08-27 2013-07-24 株式会社新药 促进人源性抗菌肽分泌的新化合物、其制备方法以及含有其作为活性成分的组合物
CN107233564A (zh) * 2008-10-02 2017-10-10 莱特克斯生物制药股份有限公司 生物膜的治疗
CN115666237A (zh) * 2020-03-27 2023-01-31 山尼饮料责任有限公司 抗菌管状导管

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161121A0 (en) * 2001-10-03 2004-08-31 Harvard College Copolymers for suppression of autoimmune diseases, and methods of use
US7674771B2 (en) * 2003-10-29 2010-03-09 Toagosei Co., Ltd Antimicrobial peptides and utilization of the same
US7655221B2 (en) 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
US8303962B2 (en) * 2009-01-06 2012-11-06 C3 Jian, Inc. Antibacterial and antifungal peptides
WO2013124436A1 (en) * 2012-02-23 2013-08-29 University Of East London Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains
US10507227B2 (en) * 2014-04-15 2019-12-17 The Hospital For Sick Children Cationic antimicrobial peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
US5714577A (en) * 1996-01-26 1998-02-03 University Of Pittsburgh Antimicrobial peptides
WO1997029765A1 (en) * 1996-02-16 1997-08-21 The Regents Of The University Of California Antimicrobial peptides and methods of use
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US6043220A (en) * 1997-12-03 2000-03-28 Intrabiotics Pharmaceuticals, Inc. Threonine-containing protegrins
WO1999065506A2 (en) * 1998-06-12 1999-12-23 Micrologix Biotech Inc. Cancer therapy with indolicidin or cationic peptides and their polymer conjugates

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107233564A (zh) * 2008-10-02 2017-10-10 莱特克斯生物制药股份有限公司 生物膜的治疗
CN102481369A (zh) * 2009-06-16 2012-05-30 东海大学 抗革兰氏阴性菌剂
CN103221383A (zh) * 2010-08-27 2013-07-24 株式会社新药 促进人源性抗菌肽分泌的新化合物、其制备方法以及含有其作为活性成分的组合物
CN103221383B (zh) * 2010-08-27 2016-04-20 株式会社新药 促进人源性抗菌肽分泌的新化合物、其制备方法以及含有其作为活性成分的组合物
CN115666237A (zh) * 2020-03-27 2023-01-31 山尼饮料责任有限公司 抗菌管状导管

Also Published As

Publication number Publication date
WO2003000277A2 (en) 2003-01-03
US20040235745A1 (en) 2004-11-25
ZA200309580B (en) 2004-07-28
JP2004534084A (ja) 2004-11-11
EP1401478A2 (en) 2004-03-31
IL159274A0 (en) 2004-06-01
AU2002317071B2 (en) 2008-01-31
CA2451310A1 (en) 2003-01-03
US20080234188A1 (en) 2008-09-25
CA2451310C (en) 2014-02-25
WO2003000277A3 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
CN1217697C (zh) 小带素的肽拮抗剂及其用途
CN1145695C (zh) 抗真菌蛋白
CN1054900A (zh) 由对β-内酰胺抗生素敏感的微生物引起的感染的治疗方法及其组合物
CN1251041A (zh) 精细调节的protegrin
CN1161372C (zh) 具有生物学活性的新肽
CN1423656A (zh) 作为抗菌剂的脂肽
CN1425025A (zh) 作为抗菌剂的新颖的脂肽
CN1216549A (zh) 抗病原肽及包含该肽的组合物
CN1175954A (zh) 由hla分子提呈的分离的九肽及其应用
CN1735422A (zh) 新旋素:抗微生物肽
CN1925866A (zh) 细菌感染的治疗
CN1650005A (zh) 抗菌性多肽及其应用
CN1839149A (zh) 能够结合转化生长因子β1(TGF－β1)的肽
CN1136778A (zh) 与一种精子区带结合蛋白的自身抗原性抗原决定基相对应的精子抗原
CN1046462A (zh) 生物活性肽和抗菌素的组合物及其应用
CN1269837C (zh) 一组合成抗菌肽
CN1260353C (zh) 用于治疗细菌感染的多价噬菌体制备方法
CN1589280A (zh) 微生物感染的治疗
CN101068563A (zh) 新型抗微生物肽
CN1894277A (zh) 周期性抗微生物肽
CN1043263A (zh) 生物活性肽和一些阴离子的组合物及其治疗作用
CN1597698A (zh) 阳离子抗菌肽
CN1724566A (zh) 抗菌、抗内毒素变构肽分子及其合成方法
CN1660889A (zh) 低溶血性的抗菌胜肽及其使用方法
CN1245418C (zh) 一组新的合成抗菌肽及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication